ONCTERNAL THERAPEUTICS INC's ticker is ONCT and the CUSIP is 68236P107. A total of 27 filers reported holding ONCTERNAL THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $43,330 | -13.0% | 144,434 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $49,830 | -56.1% | 144,434 | 0.0% | 0.00% | -66.7% |
| Q1 2023 | $113,381 | -21.5% | 144,434 | 0.0% | 0.00% | -25.0% |
| Q4 2022 | $144,434 | +12.0% | 144,434 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $129,000 | -19.4% | 144,434 | 0.0% | 0.00% | -20.0% |
| Q2 2022 | $160,000 | -20.4% | 144,434 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $201,000 | +22.6% | 144,434 | +100.0% | 0.01% | +25.0% |
| Q4 2021 | $164,000 | -45.5% | 72,217 | 0.0% | 0.00% | -50.0% |
| Q3 2021 | $301,000 | -12.2% | 72,217 | 0.0% | 0.01% | -20.0% |
| Q2 2021 | $343,000 | -42.9% | 72,217 | 0.0% | 0.01% | -60.0% |
| Q1 2021 | $601,000 | +69.8% | 72,217 | 0.0% | 0.02% | +56.2% |
| Q4 2020 | $354,000 | +187.8% | 72,217 | 0.0% | 0.02% | +128.6% |
| Q3 2020 | $123,000 | -40.0% | 72,217 | 0.0% | 0.01% | -46.2% |
| Q2 2020 | $205,000 | -3.3% | 72,217 | 0.0% | 0.01% | -23.5% |
| Q1 2020 | $212,000 | – | 72,217 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 210,000 | $187,000 | 0.26% |
| Quantum Private Wealth, LLC | 461,356 | $411,000 | 0.26% |
| Beta Wealth Group, Inc. | 32,000 | $29,000 | 0.02% |
| BRIGHTON JONES LLC | 334,053 | $298,000 | 0.02% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 53,554 | $48,000 | 0.01% |
| AXXCESS WEALTH MANAGEMENT, LLC | 87,863 | $78,000 | 0.01% |
| Balboa Wealth Partners | 17,500 | $16 | 0.01% |
| IPG Investment Advisors LLC | 23,691 | $21,123,000 | 0.01% |
| DOWLING & YAHNKE LLC | 150,464 | $134,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 35,012 | $31,000 | 0.00% |